TO THE EDITOR, We read with great interest the recent Research Letter by Noritomi et al. proposing the use of sedative defined daily dose (DDD) as a monitoring tool in critically ill patients.() The pursuit of standardized metrics to quantify sedative exposure is both timely and relevant, particularly in an era increasingly focused on sedation …
Ferhan Demirer Aydemir (2026) studied this question.